FDA warns Genentech clinical investigator working on preventive flu antiviral trial
The FDA on Tuesday released a warning letter that it sent to a clinical investigator involved in Genentech’s Phase IIIb trial for the antiviral Xofluza …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.